STRS Ohio’s ClearPoint Neuro CLPT Stock Holding History

STRS Ohio’s Portfolio CLPT Stock Details CLPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-21,800	Closed	-$260K	–	2211
2025 Q2	$260K	Buy	+21,800	New	+$274K	﹤0.01%	1567
2021 Q3	–	Sell	-4,400	Closed	-$83K	–	2249
2021 Q2	$83K	Buy	+4,400	New	+$85K	﹤0.01%	2015

Other funds holding CLPT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Focus Partners Wealth Boston, Massachusetts $89.9B AUM 20.5% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Lane Generational Dover, Massachusetts $126M AUM 53.89% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

BCM

Boone Capital Management Atlanta, Georgia $326M AUM 86.31% 1-Year Est. Return

STRS Ohio's CLPT Position: Q3 2025 in Review

STRS Ohio sold out of ClearPoint Neuro (CLPT) in Q3 2025, closing a stake of 21,800 shares — an estimated $260K sold.

STRS Ohio first reported a position in CLPT in Q2 2021 and held it in 2 quarters. The position peaked at $260K in Q2 2025. 107 funds tracked by Wall St. Rank hold CLPT as of Q3 2025.

STRS Ohio reported no remaining ClearPoint Neuro position as of Q3 2025 after selling out during the quarter.
STRS Ohio sold 21,800 ClearPoint Neuro shares in Q3 2025, an estimated $260K.
STRS Ohio first reported a position in ClearPoint Neuro in Q2 2021 and held it in 2 quarters.
STRS Ohio's ClearPoint Neuro position peaked at $260K in Q2 2025.
107 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q3 2025.

Based on STRS Ohio's 13F filing for Q3 2025, filed 30 Oct 2025.